2013
DOI: 10.1371/journal.pone.0083200
|View full text |Cite
|
Sign up to set email alerts
|

The Wall Eclipsing Sign on Pulmonary Artery Computed Tomography Angiography Is Pathognomonic for Pulmonary Artery Sarcoma

Abstract: BackgroundThe objective of this study was to evaluate the imaging characteristics of pulmonary artery sarcoma (PAS) on pulmonary artery computed tomography angiography (PACTA) that can be used to differentiate between PAS and pulmonary thromboembolic diseases, including chronic thromboembolic pulmonary hypertension (CTEPH) and acute pulmonary embolism (APE).MethodsThe clinical data and imaging characteristics of 12 patients with PAS, 156 patients with CTEPH, and 426 patients with APE who were treated at Beijin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
69
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 71 publications
(72 citation statements)
references
References 24 publications
(23 reference statements)
1
69
0
1
Order By: Relevance
“…Chest X-ray examinations of patients with PAS are often nonspecific, and may reveal a hilar mass, protruding pulmonary artery segment, unilateral pulmonary artery, proximal branch expansion, lung nodules, right ventricular enlargement and sparse peripheral vasculature (8,19). CTPA and pulmonary magnetic resonance imaging (MRI) present advantages for the diagnosis of PAS (7,18,20). CTPA may clearly reveal the involvement of lesions in the pulmonary artery, right ventricular outflow tract and pulmonary valve (17).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Chest X-ray examinations of patients with PAS are often nonspecific, and may reveal a hilar mass, protruding pulmonary artery segment, unilateral pulmonary artery, proximal branch expansion, lung nodules, right ventricular enlargement and sparse peripheral vasculature (8,19). CTPA and pulmonary magnetic resonance imaging (MRI) present advantages for the diagnosis of PAS (7,18,20). CTPA may clearly reveal the involvement of lesions in the pulmonary artery, right ventricular outflow tract and pulmonary valve (17).…”
Section: Discussionmentioning
confidence: 99%
“…It has an incidence rate of 0.001-0.030% (2). Since 1923, when the first case of PAS was reported by Mandelstamm (3), ≤300 cases have been reported to date worldwide (4)(5)(6)(7). The etiology of PAS is unknown, and this disease has a poor prognosis (5).…”
Section: Introductionmentioning
confidence: 99%
“…The majority of patients have demonstrated insidious onset, predominantly involving progressive dyspnea, chest pain, coughing, hemoptysis, syncopes, fever, fatigue and weight loss (4,6,8,15,16). X-rays of these patients typically show a prominent hilar shadow, sparse texture of the peripheral vasculature, lung nodules and enlargement of the heart.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, previous studies have recommended that the CT data be used together with positron-emission tomography (PET)-CT results for the diagnosis of PAS (4,(7)(8)(9). The performance of 18 F-fludeoxyglucose ( 18 FDG) PET-CT in patients with PTE or CTEPH showed no increase in radiotracer intake, whereas in patients with PAS, 18 FDG PET-CT showed an increase in radiotracer uptake, which may help to differentiate between the two diseases.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation